Cargando…

Cost-Effectiveness Analysis of Local Ablation and Surgery for Liver Metastases of Oligometastatic Colorectal Cancer

SIMPLE SUMMARY: Colorectal cancer is among the most prevalent cancers worldwide, with every second patient developing liver metastasis during their illness. For treatment of oligometastatic patients, there are several alternatives such as surgery, microwave ablation (MWA) and radiofrequency ablation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Froelich, Matthias F., Schnitzer, Moritz L., Rathmann, Nils, Tollens, Fabian, Unterrainer, Marcus, Rennebaum, Shereen, Seidensticker, Max, Ricke, Jens, Rübenthaler, Johannes, Kunz, Wolfgang G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037107/ https://www.ncbi.nlm.nih.gov/pubmed/33806059 http://dx.doi.org/10.3390/cancers13071507

Ejemplares similares

Cost-Effectiveness Analysis of Local Treatment in Oligometastatic Disease
por: Mehrens, Dirk, et al.
Publicado: (2021)

Cost-Effectiveness of MR-Mammography in Breast Cancer Screening of Women With Extremely Dense Breasts After Two Rounds of Screening
por: Tollens, Fabian, et al.
Publicado: (2021)

Interstitial High-Dose-Rate Brachytherapy of Liver Metastases in Oligometastatic Patients
por: Walter, Franziska, et al.
Publicado: (2021)

Economic potential of abbreviated breast MRI for screening women with dense breast tissue for breast cancer
por: Tollens, Fabian, et al.
Publicado: (2022)

Follow-Up 18F-FDG PET/CT versus Contrast-Enhanced CT after Ablation of Liver Metastases of Colorectal Carcinoma—A Cost-Effectiveness Analysis
por: Schnitzer, Moritz L., et al.
Publicado: (2020)

Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival
por: Seidensticker, Ricarda, et al.
Publicado: (2018)

Cost-Effectiveness of Digital Breast Tomosynthesis vs. Abbreviated Breast MRI for Screening Women with Intermediate Risk of Breast Cancer—How Low-Cost Must MRI Be?
por: Tollens, Fabian, et al.
Publicado: (2021)

(68)Ga-DOTATATE PET/CT and MRI with Diffusion-Weighted Imaging (DWI) in Short- and Long-Term Assessment of Tumor Response of Neuroendocrine Liver Metastases (NELM) Following Transarterial Radioembolization (TARE)
por: Ingenerf, Maria, et al.
Publicado: (2021)

Additional MRI for initial M-staging in pancreatic cancer: a cost-effectiveness analysis
por: Gassert, Felix G., et al.
Publicado: (2021)

Diagnostic Workup for Patients with Solid Renal Masses: A Cost-Effectiveness Analysis
por: Runtemund, Jasmin, et al.
Publicado: (2022)

Supplemental (18)F-FDG-PET/CT for Detection of Malignant Transformation of IPMN—A Model-Based Cost-Effectiveness Analysis
por: Bicu, Felix, et al.
Publicado: (2021)

Cost-effectiveness analysis of MRI, CE-CT and 18F-FDG PET/CT for detecting colorectal liver metastases eligible for hepatic resection
por: Schnitzer, Moritz L., et al.
Publicado: (2023)

Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma—Role of Interventional Radiology
por: Fabritius, Matthias P., et al.
Publicado: (2021)

Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)
por: Seidensticker, Max, et al.
Publicado: (2015)

Sarcoid-Like Reaction in Non-Hodgkin’s Lymphoma—A Diagnostic Challenge for Deauville Scoring on (18)F-FDG PET/CT Imaging
por: Winkelmann, Michael, et al.
Publicado: (2021)

Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases
por: Seidensticker, Max, et al.
Publicado: (2010)

PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions
por: Unterrainer, Marcus, et al.
Publicado: (2020)

Diagnostic Performance of Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Solid Renal Masses
por: Geyer, Thomas, et al.
Publicado: (2020)

Oligometastatic prostate cancer: Metastases-directed therapy?
por: Van Poppel, Hein, et al.
Publicado: (2016)

Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver
por: Kim, Myungsoo, et al.
Publicado: (2014)

Stereotactic ablative radiotherapy for oligometastatic prostate cancer
por: Gallizia, Elena, et al.
Publicado: (2022)

Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (HDR) brachytherapy of liver metastases
por: Damm, Robert, et al.
Publicado: (2022)

Treatment of hepatic pancreatic ductal adenocarcinoma metastases with high-dose-rate image-guided interstitial brachytherapy: a single center experience
por: Drewes, Ralph, et al.
Publicado: (2019)

Superior outcomes of nodal metastases compared to visceral sites in oligometastatic colorectal cancer treated with stereotactic ablative radiotherapy
por: O'Cathail, Sean M., et al.
Publicado: (2020)

Efficacy and safety of percutaneous computed tomography-guided high-dose-rate interstitial brachytherapy in treatment of oligometastatic lymph node metastases of retroperitoneal space
por: Heinze, Constanze, et al.
Publicado: (2019)

The Potential and Emerging Role of Quantitative Imaging Biomarkers for Cancer Characterization
por: Tharmaseelan, Hishan, et al.
Publicado: (2022)

Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases
por: Rühl, Ricarda, et al.
Publicado: (2010)

Transformation of diffuse large B cell lymphoma into dendritic sarcoma under CAR T cell therapy detected on (18)F-FDG PET/CT
por: Winkelmann, Michael, et al.
Publicado: (2020)

Peripheral blood lymphocyte changes after stereotactic ablative body radiotherapy to lung or liver metastases in patients with oligometastatic cancers
por: Novikov, Sergey Nikolaevich, et al.
Publicado: (2023)

Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
por: König, Laila, et al.
Publicado: (2020)

Identification of CT Imaging Phenotypes of Colorectal Liver Metastases from Radiomics Signatures—Towards Assessment of Interlesional Tumor Heterogeneity
por: Tharmaseelan, Hishan, et al.
Publicado: (2022)

Early monocyte response following local ablation in hepatocellular carcinoma
por: Kimm, Melanie A., et al.
Publicado: (2022)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients
por: Morales-Orue, Ignacio, et al.
Publicado: (2020)

(18)F-FDG PET/CT for Response Assessment in Pediatric Sebaceous Carcinoma of the Parotid Gland
por: Holzgreve, Adrien, et al.
Publicado: (2020)

In response to: PSMA PET/CT cost-effectiveness analysis in the USA: a response to a published commentary
por: Holzgreve, Adrien, et al.
Publicado: (2023)

Tumor classification of gastrointestinal liver metastases using CT-based radiomics and deep learning
por: Tharmaseelan, Hishan, et al.
Publicado: (2023)

Artifact characterization of Nitinol needles in magnetic resonance imaging-guided musculoskeletal interventions at 3.0 tesla: a phantom study
por: Schmidt, Vanessa Franziska, et al.
Publicado: (2023)

Local ablative radiotherapy for oligometastatic non-small cell lung cancer
por: Suh, Yang-Gun, et al.
Publicado: (2019)

Knowing When to Use Stereotactic Ablative Radiation Therapy in Oligometastatic Cancer
por: Franceschini, Davide, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0fgbe4mosqm5vutnsnskftlpr7